"Leukoplakia, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A white patch seen on the oral mucosa. It is considered a premalignant condition and is often tobacco-induced. When evidence of Epstein-Barr virus is present, the condition is called hairy leukoplakia (LEUKOPLAKIA, HAIRY).
| Descriptor ID |
D007972
|
| MeSH Number(s) |
C04.588.443.591.545 C04.834.512.513 C07.465.565.545 C23.300.816.513
|
| Concept/Terms |
Leukoplakia, Oral- Leukoplakia, Oral
- Leukoplakias, Oral
- Oral Leukoplakia
- Oral Leukoplakias
Leukokeratosis, Oral- Leukokeratosis, Oral
- Leukokeratoses, Oral
- Oral Leukokeratoses
- Oral Leukokeratosis
- Keratosis, Oral
|
Below are MeSH descriptors whose meaning is more general than "Leukoplakia, Oral".
Below are MeSH descriptors whose meaning is more specific than "Leukoplakia, Oral".
This graph shows the total number of publications written about "Leukoplakia, Oral" by people in this website by year, and whether "Leukoplakia, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2018 | 1 | 1 | 2 |
| 2020 | 2 | 1 | 3 |
| 2021 | 2 | 0 | 2 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
| 2025 | 1 | 0 | 1 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukoplakia, Oral" by people in Profiles.
-
Artificial intelligence model predicts malignant transformation of oral leukoplakia and optimizes interventions. Oral Oncol. 2026 Jul; 178:107982.
-
Machine learning models for predicting recurrence and malignant transformation of oral leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol. 2026 02; 141(2):176-186.
-
Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial. JAMA Oncol. 2024 01 01; 10(1):32-41.
-
Practice patterns for initial management of oral leukoplakia amongst otolaryngologists and oral and maxillofacial surgeons. Oral Oncol. 2023 04; 139:106341.
-
Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions. JCI Insight. 2021 09 08; 6(17).
-
Proliferative Verrucous Leukoplakia: An Expert Consensus Guideline for Standardized Assessment and Reporting. Head Neck Pathol. 2021 Jun; 15(2):572-587.
-
Liver Transplant for Management of Hepatic Complications of Dyskeratosis Congenita: A Case Report. Exp Clin Transplant. 2022 07; 20(7):702-705.
-
Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study. J Natl Cancer Inst. 2020 10 01; 112(10):1047-1054.
-
Response to Brandt, Bednarz-Knoll, Kleinheinz et al. J Natl Cancer Inst. 2020 09 01; 112(9):970-971.
-
Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 06; 125(6):650-669.